Panu Jaakkola

Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors (2020)

JAMA Oncology

Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Barbara Hermes, Jochen Schütte, Silke Cameron, Peter Hohenberger, Philipp J. Jost, Salah-Eddin Al-Batran, Lars H. Lindner, Sebastian Bauer, Eva Wardelmann, Bengt Nilsson, Raija Kallio, Panu Jaakkola, Jouni Junnila, Thor Alvegård, Peter Reichardt

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma (2019)

Journal of Biological Chemistry

Petra Miikkulainen, Heidi Högel, Fatemeh Seyednasrollah, Krista Rantanen, Laura L. Elo, Panu M. Jaakkola

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Transportable system enabling multiple irradiation studies under simultaneous hypoxia in vitro (2018)

Radiation Oncology

Olli Metsälä, Joose Kreutzer, Heidi Högel, Petra Miikkulainen, Pasi Kallio, Panu M Jaakkola

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma (2017)

Cancer and Metabolism

Miikkulainen P, Högel H, Rantanen K, Suomi T, Kouvonen P, Elo LL, Jaakkola PM

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Overall Survival and Metastasis Resections in Patients with Metastatic Colorectal Cancer Using Electorinic Medical Records (2017)

Journal of Gastrointestinal Surgery

Heervä Eetu, Lavonius Maija, Jaakkola Panu, Minn Heikki, Ristamäki Raija

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

ROTS: reproducible RNA-seq biomarker detector-prognostic markers for clear cell renal cell cancer (2016)

Nucleic Acids Research

Seyednasrollah F, Rantanen K, Jaakkola P, Elo LL

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27 (2015)

Molecular Cancer

Hogel H, Miikkulainen P, Bino L, Jaakkola PM

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

HIF prolyl hydroxylase PHD3 maintains hypoxic cell cycle through cyclin-dependent kinase inhibitor P27 (2014)

European Journal of Cancer

Hogel H, Miikkulainen P, Bino L, Jaakkola PM

(O2 Muu)

VHL-dependent changes in global kinome expression in renal cell carcinoma (2014)

European Journal of Cancer

Rantanen K, Kouvonen P, Corthals GL, Jaakkola PM

(O2 Muu)

Uptake of [18F]EF5 as a Tracer for Hypoxic and Aggressive Phenotype in Experimental Head and Neck Squamous Cell Carcinoma (2014)

Translational Oncology

Silén J, Högel H, Kivinen K, Silvoniemi A, Forsback S, Löyttyniemi E, Solin O, Grénman R, Minn H, Jaakkola PM, Grönroos TJ

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Contact

Links

Areas of expertise

Publications

Sort by:

Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors (2020)

Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma (2019)

Transportable system enabling multiple irradiation studies under simultaneous hypoxia in vitro (2018)

HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma (2017)

Overall Survival and Metastasis Resections in Patients with Metastatic Colorectal Cancer Using Electorinic Medical Records (2017)

ROTS: reproducible RNA-seq biomarker detector-prognostic markers for clear cell renal cell cancer (2016)

Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27 (2015)

HIF prolyl hydroxylase PHD3 maintains hypoxic cell cycle through cyclin-dependent kinase inhibitor P27 (2014)

VHL-dependent changes in global kinome expression in renal cell carcinoma (2014)

Uptake of [18F]EF5 as a Tracer for Hypoxic and Aggressive Phenotype in Experimental Head and Neck Squamous Cell Carcinoma (2014)